Benzodiazepine Use among Depressed Patients Treated in Mental Health Settings

American Journal of Psychiatry

Volumn 161, Issue 4, 2004, Pages 654-661

  Valenstein, Marcia ^a   Taylor, Kiran Khanujua ^b   Austin, Karen ^b   Kales, Helen C ^b   McCarthy, John F ^b   Blow, Frederic C ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; ESTAZOLAM; FLURAZEPAM; HALAZEPAM; LORAZEPAM; OXAZEPAM; PRAZEPAM; QUAZEPAM; TEMAZEPAM; TRIAZOLAM;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; DEMOGRAPHY; DEPRESSION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; PRESCRIPTIONS, DRUG; REGISTRIES; SUBSTANCE-RELATED DISORDERS;

EID: 1842585686     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.4.654     Document Type: Article

References (43)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19
2. Beekman ATF, Anton EB, van Balkom JLM, Deeg DJH, van Dyck R, van Tilburg W: Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000; 157:89-95
3. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG: Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996; 30:17-30
4. Berk M: Selective serotonin reuptake inhibitors in mixed anxiety-depression. Int Clin Psychopharmacol 2000; 15:S41-S45
5. Doraiswamy PM: Contemporary management of comorbid anxiety and depression in geriatric patients. J Clin Psychiatry 2001; 62:30-35
6. Simon GE, VonKorff M, Barlow W, Pabiniak C, Wagner E: Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996; 49:1067-1073
7. Tu K, Mamdani MM, Hux JE, Tu J: Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc 2001; 49:1341-1345
8. Taylor S, McCracken CF, Wilson KC, Copeland JR: Extent and appropriateness of benzodiazepine use: results from an elderly urban community. Br J Psychiatry 1998; 173:433-438
9. Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA: Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry 1999; 14:280-284
10. Blazer D, Hybels C, Simonsick E, Hanlon JT: Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: a racial comparison. J Am Geriatr Soc 2000; 48:1073-1079
11. Bartels SJ, Horn S, Sharkey P, Levine K: Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med 1997; 27:215-231
12. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA: National trends in the outpatient treatment of depression. JAMA 2002; 287:203-209
13. Birkenhager TK, Moleman P, Nolen WA: Benzodiazepines for depression? a review of the literature. Int Clin Psychopharmacol 1995; 10:181-195
14. Furukawa TA, Streiner DL, Young LT: Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev 2002; 1:CD001026
15. Schweizer E, Rickels K: Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl 1998; 393:95-101
16. Hanlon JT, Horner RD, Schmader KE, Fillenbaum GG, Lewis IK, Wall WE Jr, Landerman LR, Pieper CF, Blazer DG, Cohen HJ: Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998; 64:684-692
17. McAndrews M, Weiss RT, Sandor P, Taylor A, Carlen PL, Shapiro CM: Cognitive effects of long-term benzodiazepine use in older adults. Hum Psychopharmacol 2003; 18:51-57
18. Paterniti S, Dufouil C, Alperovitch A: Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002; 22:285-293
19. Fastborn J, Forsell Y, Winblad B: Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12:14-17
20. Hemmelgarn B, Suissa S, Huang A, Boivon J-F, Pinard G: Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278:27-31
21. Ray WA, Fought RL, Decker MD: Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136:873-883
22. Leipzig RM, Cumming RG, Tinetti ME: Drugs and falls in older people: a systematic review and meta-analysis, II: cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47:40-50
23. Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F: Benzodiazepines and the risk of falling leading to femur fractures: dosage more important than elimination half-life. Arch Intern Med 1995; 155:1801-1807
24. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (Study of Osteoporotic Fractures Research Group): Risk factors for hip fracture in white women. N Engl J Med 1995; 332:767-773
25. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J: Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158:892-898
26. Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, Hanlon JT, Nevitt MC, Whooley MA: Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003; 163:949-957
27. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Major Depressive Disorder (Revision). Am J Psychiatry 2000; 157(April suppl)
28. Texas Medication Algorithm Project (TMAP): Depression Module. Austin, Texas Department of Mental Health, 1998
29. Kaplan HI, Sadock BJ (eds): Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 8th ed. Philadelphia, Lippincott, Williams & Williams, 1998
30. Galanter M, Kleber HD (eds): Textbook of Substance Abuse Treatment, 2nd ed. Washington, DC, American Psychiatric Press, 1999
31. Graham AW, Schultz TK (eds): Principles of Addiction Medicine, 2nd ed. Chevy Chase, Md, American Association of Addiction Medicine, 1998
32. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383
33. Veterans Health Services and Research Administration: United States, by Region - Map (Eastern, Central, Southern, Western). Washington, DC, US Government Printing Office, 1991
34. Dybwad TB, Kjolsrod L, Eskerud J, Laerum E: Why are some doctors high-prescribers of benzodiazepines and minor opiates? a qualitative study of GPs in Norway. Fam Pract 1997; 14:361-368
35. Bendtsen P, Hensing G, McKenzie L, Stridsman AK: Prescribing benzodiazepines - a critical incident study of a physician dilemma. Soc Sci Med 1999; 49:459-467
36. Hylan T, Crown WH, Meneades L, Heiligenstein JH, Melfi CA, Croghan TW, Buesching DP: SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis. Med Care 1999; 37:AS36-AS44
37. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence depression. Arch Gen Psychiatry 1998; 55:1128-1132
38. Couvee JE, Timmermans MA, Zitman FG: The long-term outcome of a benzodiazepine discontinuation programme in depressed outpatients. J Affect Disord 2002; 70:133-141
39. Londborg PD, Smith WT, Glaudin V, Painter JR: Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. J Affect Disord 2000; 61:73-79
40. Petty F, Trivedi MH, Fulton M, Rush AJ: Benzodiazepines as antidepressants: does GABA play a role in depression? Biol Psychiatry 1995; 38:578-591
41. Lin K-M: Biological differences in depression and anxiety across races and ethnic groups. J Clin Psychiatry 2001; 62:13-19
42. Masimirembwa CM, Hasler JA: Genetic polymorphism of drug metabolising enzymes in African populations: implications for the use of neuroleptics and antidepressants. Brain Res Bull 1997; 44:561-571
43. Rickels K, Case WG, Schweizer E, Garcia-Espana F, Fridman R: Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am J Psychiatry 1991; 148:757-761